Predict your next investment

HEALTHCARE | Medical Devices & Equipment
parsortix.us

See what CB Insights has to offer

Founded Year

2006

Stage

Grant | Alive

Total Raised

$150K

Last Raised

$150K | 12 yrs ago

About Parsortix

Parsortix technology is a physical separation device that enables the user to capture particles of different types suspended in fluid media using a patented separation process. The device design can be 'tuned' to capture particles of different sizes and has a wide range of potential applications in medical devices and diagnostics. The device has been successfully shown to be capable of separating fetal cells from whole peripheral maternal blood, and to be capable of capturing and separating different kinds of white blood cells from whole blood.

Parsortix Headquarter Location

3711 Market Street University City Science Center, 8th Floor

Philadelphia, Pennsylvania, 19104,

United States

215-966-6240

Latest Parsortix News

ANGLE hails Barts Hospital prostate cancer study

Nov 11, 2021

ANGLE hails Barts Hospital prostate cancer study Researchers from the London hospital used the ANGLE's Parsortix liquid biopsy to capture and analyse circulating tumour cells ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said a poster showcasing the findings from a Barts Cancer Institute study into metastatic prostate cancer using the company’s liquid biopsy system was presented at the National Cancer Research Institute (NCRI) Festival on Wednesday (Nov 10). Researchers from the London hospital concluded that KLK2 gene expression on circulating tumour cells captured by ANGLE’s Parsortix equipment was a more effective biomarker for assessing the likelihood of disease progression than the current standard of care. Chief executive Andrew Newland said: “Their findings not only demonstrated the Parsortix system's potential to guide treatment decisions but also its ability to help identify new biomarkers for assessing the likelihood of progression in prostate cancer and as possible targets for new drug therapy. “This evidence provides further support for our pharma services business which offers longitudinal analysis for drug trials in multiple cancers and for our planned studies to develop a prostate cancer assay to offer as a laboratory-developed test from our own laboratories." ANGLE’s Parsortix system is able to capture circulating tumour cells that provide the tell-tale signs of cancer. Researchers are using the technology to further understand the disease, its progression and to fine-tune treatment options. Quick facts: ANGLE PLC

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Parsortix Patents

Parsortix has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/12/2013

4/25/2017

Nanotechnology, Molecular biology, Cell biology, Biotechnology, Clusters of differentiation

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/12/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/25/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Nanotechnology, Molecular biology, Cell biology, Biotechnology, Clusters of differentiation

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.